COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
3.200
+0.050 (1.59%)
Apr 25, 2025, 4:00 PM EDT - Market closed

COSCIENS Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
10109154427
Upgrade
Market Cap Growth
6.71%6.71%-38.75%-64.65%64.32%44.53%
Upgrade
Enterprise Value
-5-7-30-39-244
Upgrade
Last Close Price
3.222.777.4412.7235.5342.55
Upgrade
Debt / Equity Ratio
0.180.180.080.010.000.01
Upgrade
Debt / EBITDA Ratio
---0.03--
Upgrade
Debt / FCF Ratio
---0.04--
Upgrade
Asset Turnover
0.330.330.180.210.090.13
Upgrade
Inventory Turnover
1.451.451.9839.841.923.31
Upgrade
Quick Ratio
2.612.615.327.498.885.60
Upgrade
Current Ratio
3.323.328.597.889.125.82
Upgrade
Return on Equity (ROE)
-89.54%-89.54%-12.27%7.77%-25.28%-95.24%
Upgrade
Return on Assets (ROA)
-21.13%-21.13%-7.25%3.97%-9.25%-13.00%
Upgrade
Return on Capital (ROIC)
-32.53%-32.53%-9.86%6.06%-16.29%-62.56%
Upgrade
Return on Capital Employed (ROCE)
---8.80%--
Upgrade
Buyback Yield / Dilution
-39.74%-39.74%0.39%-61.37%-179.74%-134.83%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q